Health care stocks rose Thursday with the NYSE Health Care Index up 1% and the Health Care Select Sector SPDR Fund (XLV) adding 1.2%.
The iShares Biotechnology ETF (IBB) advanced 1%.
In corporate news, Kazia Therapeutics' (KZIA) shares jumped 38% after the company announced the regulatory approval and launch of a trial evaluating the combination of its investigational drug paxalisib and immunotherapy in people with advanced breast cancer.
Valneva (VALN) shares rose 3.6% after the company won a $32.8 million contract from the US Department of Defense for the supply of Ixiaro, a Japanese encephalitis vaccine.
Ironwood Pharmaceuticals (IRWD) shares slumped 38%, a day after the company announced a 50% cut in its workforce due to "ongoing pricing pressures."
Cargo Therapeutics (CRGX) shares tumbled 74%, a day after the company announced plans to discontinue a phase 2 trial of firicabtagene autoleucel for people with large B-cell lymphoma and reduce its workforce by 50%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.